m+Medelevator.RU
← Поиск публикаций
Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 1977

Use of 99mTc-Cu-DTPA complex as a renal function agent.

СтатьяПоддержка службы здравоохранения СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Chervu L R, Lee H B, Goyal Q, Blaufox M D

Аннотация

The use of cuprous ion as a reducing agent for pertechnetate is described for the first time. The potential usefulness of a 99mTc-Cu-DTPA complex as a renal function agent was evaluated by organ distribution studies in animals and by simultaneous continuous-infusion and single-injection clearance studies. Radioiodinated iothalamate was used as a standard for the measurement of GFR. The ratio for the clearance with the new copper complex to that with iothalamate is close to unity, both for continuous infusion (0.97 +/- 0.01 s.e) and for single injection (1.05 +/- 0.03). The coefficients of correlation are similarly close to unity: 0.96 and 0.99, respectively. Dialysis of plasma samples obtained after injection of 99mTc-Cu-DTPA into bilaterally nephrectomized rats indicates that only small amounts (less than 4%) of the complex are protein-bound. These data and the low toxicity of the copper preparation in animals appear to justify its investigation for kidney function measurement and imaging in man as well as its use as a GFR agent in animal studies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты